Feature Channels:

Vision

Add to Favorites | Subscribe | Share

Filters:

  • (Press "esc" to clear)

Medicine

Channels:

Genetics, ophthalmolgy, coloboma, Blindness, Deafness, Waardenburg syndrome, Children, National Eye Institute (NEI), National Institutes Of Health (NIH), Albinism, Genetic Testing

Media Availability: NIH Scientists Identify Disorder Causing Blindness, Deafness, Albinism and Fragile Bones

Researchers at the National Eye Institute (NEI), part of the National Institutes of Health, have identified the genetic underpinnings of a rare disorder that causes children to be born with deafness, blindness, albinism and fragile bones.

Science

Channels:

zika, Retina, Vision, Blindness

Wayne State Vision Researchers Show Zika Virus Can Damage Retina and Cause Blindness

Scientists at the Wayne State University School of Medicine Department of Ophthalmology at the Kresge Eye Institute have shown that the Zika virus can replicate in the eye’s retinal cells, causing severe tissue damage and even blindness. The research is supported in part by Research to Prevent Blindness.

Medicine

Channels:

Diabetes, Childhood Obesity, Diabetic Retinopathy, Diabetic Retinal Screening, Pediatric Care, Eye Care, Vision, Ophthalmology

Do eye screening guidelines adequately catch diabetic retinopathy in youth?

By the time current screening recommendations kicked in, 18% of youth with type 1 diabetes already had diabetic retinopathy, according to a study led by University of Michigan Kellogg Eye Center.

Business

Channels:

Kimberlee Jones, John Tracy Clinic, JTC, Vice President, Chief Development Officer, Pediatric hearing loss, early intervention services, Hearing Loss

John Tracy Clinic Welcomes Kimberlee Jones as VP and Chief Development Officer

Ms. Jones brings more than two decades of fundraising experience to JTC.

Medicine

Channels:

Research On Retinal Pigment Epithelial (RPE) Cells Promises New Future Treatment for Glaucoma Patients

Scientific research builds its own momentum as one discovery triggers another, building an ongoing wave of unexpected possibilities. In the world of glaucoma, such a surge began when advances in stem cell research opened doors experts had never imagined.

Medicine

Channels:

Research, vision research awards, glaucoma research, Glaucoma Research Foundation, glaucoma researcher

Dr. Richard Libby Awarded 2017 Shaffer Prize for Innovative Glaucoma Research

Libby-2017-Shaffer-Prize_800x600.jpg

The Shaffer Prize is awarded annually by Glaucoma Research Foundation to recognize a researcher whose project best exemplifies the pursuit of innovative ideas in the quest to cure glaucoma.

Medicine

Channels:

Glaucoma, GALA, Event

Glaucoma 360 Benefit Gala Raises $520,000 for Essential Glaucoma Research and Education Programs

The Glaucoma 360 Annual Gala at San Francisco’s historic Palace Hotel honored leaders in glaucoma research innovation and visionary volunteers helping to raise awareness.

Medicine

Channels:

Retina, GARP1, GARP2, Rod cells, retinal degeneration, optical coherence tomography, Retinitis Pigmentosa

GARP2 Accelerates Retinal Degeneration in a Mouse Model

RS14539_StevenPittler-16RT-scr.jpg

Researchers show that GARP2 accelerates retinal degeneration in mice, and they have also made an important step toward creating a standardized OTC nomenclature between mice and humans for a measurement of retinal degeneration.

Medicine

Channels:

Retinopathy Of Prematurity, Blindness, Preeclampsia, Premature Birth

Is Preeclampsia a Risk or a Protective Factor in Retinopathy of Prematurity?

Mary Elizabeth Hartnett, MD, and colleagues at the John A. Moran Center and Department of Pediatrics at the University of Utah and Children’s Hospital of Wisconsin, were looking for a way to tease apart the effects of preeclampsia on the risk of developing retinopathy of prematurity (ROP), an eye disease found in premature infants. Their results, and the model they developed, were published February 14, 2017, in Scientific Reports.

Medicine

Channels:

Emergency Department, ophtahlmology, Eye Care, pinkeye, Vision, Emergency Care, Optometry

1 in 4 ER Visits for Eye Problems Aren’t Actually Emergencies, Study Finds

Pinkeye isn’t a medical emergency. Neither is a puffy eyelid. But a new study finds that nearly one in four people who seek emergency care for eye problems have those mild conditions, and recommends ways to help those patients get the right level of care.

Medicine

Channels:

Mount Sinai Health System, Mount Sinai Beth Israel, New York Eye And Ear Infirmary, Icahn School of Medicine, Otolaryngology, ENT, Otology, Neurotology, Balance, Hearing, Skull Base Surgery, Cochlear Implant, Cochlear Implants, Hearing Preservation, Ophthalmology, Ear And Hearing, Endoscopic Surgery, endoscopic skull base surgery

George Wanna, MD, FACS, Appointed Site Chair of the Department of Otolaryngology–Head and Neck Surgery at New York Eye and Ear Infirmary of Mount Sinai and Mount Sinai Beth Israel

George Wanna, MD, an internationally renowned hearing and balance surgeon and researcher, has been named the Site Chair of the Department of Otolaryngology-Head and Neck Surgery at the New York Eye and Ear Infirmary of Mount Sinai and Mount Sinai Beth Israel.

Medicine

Channels:

Dry Eye Syndrome, Contact Lenses, eye surface, Cornea, Biomaterial, cell mechanics, biomaterial adhesion, Strain, Juho Pokki, Maria C. Merola, Emily C. Hollenbeck, Namita Nabar, Gerald G. Fuller, Stanford University, Society of Rheology

Understanding the Contact of Contacts to Beat Dry Eye Syndrome

Symptoms of dry eye syndrome -- dry, red, itchy, gritty, sore eyes -- are more common among contact lens wearers. But relief may be on the horizon, thanks to a group of Stanford University researchers and their work exploring the mechanical interactions between the eye surface, the cornea and contact lenses. Ultimately, the group’s goal is to create better contact lenses that maximize comfort and alleviate dry eye symptoms, and their work will be presented at the Society of Rheology meeting being held Feb. 12-16, in Tampa, Florida.

Medicine

Channels:

Northwestern University, Feinberg School of Medicine, Research, Northwestern Medicine

Myopia Cell Discovered in Retina

cell.jpg

Northwestern Medicine scientists have discovered a cell in the retina that may cause myopia when it dysfunctions. The dysfunction may be linked to the amount of time a child spends indoors and away from natural light.

Medicine

Channels:

AMD research, AMD treatment, AMD, age-related macular degeneration, Sight loss

International Team of Researchers Develop New Model for Earlier Treatments for AMD

DrImreLengyelQueensUniversityBelfast.jpg

An international team of researchers from Queen’s University Belfast, University College London and the University of Alabama at Birmingham, USA have developed a cell culture model that could help to develop earlier treatment strategies for age-related macular degeneration (AMD).

Medicine

Channels:

Anti-Inflammatory, Anti-Cell Death Agent a Potential Treatment for Vision Loss Associated with Multiple Sclerosis

ShindlerScientificReportsmyelinimageFeb17.jpg

A new therapeutic agent tested in a mouse model of multiple sclerosis (MS) produced anti-inflammatory activity and prevented loss of cells in the optic nerve, according to a new study by researchers in the Perelman School of Medicine at the University of Pennsylvania and Noveome Biotherapeutics.

Medicine

Channels:

AMD, age-related macular degeneration, Retina, eye, Vision, Wills Eye Hospital, Ophthalmology

Early Detection of Macular Degeneration Vital to Preserve Vision, Wills Eye Expert Says

Carl D. Regillo, MD Chief of the Wills Eye Hospital Retina Service discusses what patients need to know about Age-Related Macular Degeneration

Medicine

Science

Channels:

Neuroscience, Prosthetics, Neuroprosthetics, Vision, Blindness, Neurology

UChicago Receives $2.4 Million NIH Grant to Build Visual Prosthesis

TowleVPGrantApplication0.jpg

The University of Chicago Medicine has been awarded a $2.4 million, five-year grant from the National Institutes of Health (NIH) to develop a system of wireless brain implants that might restore partial vision to people who have lost their sight.

Medicine

Channels:

Low Vision, low vision innovations, Glaucoma, Age Related Macular Degeneration, Retinitis Pigmentosa, Blindness, co-robotic cane, Computer Vision, crosswalk app, Visual Impairment

Five Innovations Harness New Technologies for People with Visual Impairment, Blindness

canecropped2usethis.jpg

During Low Vision Awareness Month, the National Eye Institute (NEI), part of the National Institutes of Health, is highlighting new technologies and tools in the works to help the 4.1 million Americans living with low vision or blindness. The innovations aim to help people with vision loss more easily accomplish daily tasks, from navigating office buildings to crossing a street.

Medicine

Channels:

Diabetic Retinopathy, Diabetic Macular Edema, Clinically Significant Macular Edema, Retina imaging, Light Issue Interactions, Cystoid Macular Edema, Color Fundus Photography, Diabetic Retinal Screening

Red 'Color Channel' May Aid in Screening for Diabetic Eye Disease

In photographs of the eye used to screen for diabetes-related eye disease, separating out the red color channel can help show some abnormalities—especially in racial/ethnic minority patients, suggests a study in the February issue of Optometry and Vision Science, official journal of the American Academy of Optometry. The journal is published by Wolters Kluwer.

Medicine

Channels:

Diabetic Eye Disease, Diabetic Retinopathy, Diabetes

Growth Factor Shown to Protect the Retina in Early Stage Diabetes

Researchers from the Schepens Eye Research Institute of Massachusetts Eye and Ear have shown that a slight increase in transforming growth factor beta (TGF-β), which is present in preclinical animal models with diabetic eye disease, protects retinal blood vessels from damage that commonly occurs in the early stages of the disease (known as diabetic retinopathy). Their findings, published in the American Journal of Pathology, may lead to targeted therapeutics that delay or prevent the development of the disease in patients.







Chat now!